M&A Deal Summary

NAMSA Acquires Suazio

On April 4, 2023, NAMSA acquired business services company Suazio

Acquisition Highlights
  • This is NAMSA’s 2nd transaction in the Business Services sector.
  • This is NAMSA’s 2nd transaction in Belgium.

M&A Deal Summary

Date 2023-04-04
Target Suazio
Sector Business Services
Buyer(s) NAMSA
Deal Type Add-on Acquisition

Target

Suazio

Antwerp, Belgium
Suazio is a data-driven Life Sciences and MedTech consultancy provides highly specialized data-driven market research, insights, analytics, and consulting services in Life Sciences and MedTech markets. Suazio was founded in 2001 and is based in Antwerp, Belgium.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

NAMSA

Northwood, Ohio, United States

Category Company
Founded 1967
Sector Medical Products
DESCRIPTION

NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. NAMSA was established in 1967 and is based in Northwood, Ohio.


DEAL STATS #
Overall 8 of 10
Sector: Business Services M&A 2 of 2
Type: Add-on Acquisition M&A Deals 8 of 9
Country: Belgium M&A 2 of 2
Year: 2023 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-04 Perfectus Biomed

Jackson, Wyoming, United States

Perfectus Biomed is a MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move Clients’ products through the development lifecycle efficiently and cost-effectively. Perfectus Biomed was founded in 2012 and is based in Jackson, Wyoming.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-18 CRI

Munich, Germany

CRI is a research institute provide the European MedTech market complete clinical research solutions to accelerate scientific outcomes to their clients. CRI was founded in 2011 and is based in Munich, Germany.

Buy -